BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20563797)

  • 1. Anabolic and antiresorptive drugs improve trabecular microarchitecture and reduce fracture risk following radiation therapy.
    Arrington SA; Fisher ER; Willick GE; Mann KA; Allen MJ
    Calcif Tissue Int; 2010 Sep; 87(3):263-72. PubMed ID: 20563797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent administration of zoledronic acid and irradiation leads to improved bone density, biomechanical strength, and microarchitecture in a mouse model of tumor-induced osteolysis.
    Arrington SA; Damron TA; Mann KA; Allen MJ
    J Surg Oncol; 2008 Mar; 97(3):284-90. PubMed ID: 18161868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair.
    Amanat N; McDonald M; Godfrey C; Bilston L; Little D
    J Bone Miner Res; 2007 Jun; 22(6):867-76. PubMed ID: 17371160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model.
    Little DG; McDonald M; Bransford R; Godfrey CB; Amanat N
    J Bone Miner Res; 2005 Nov; 20(11):2044-52. PubMed ID: 16234978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
    McDonald MM; Dulai S; Godfrey C; Amanat N; Sztynda T; Little DG
    Bone; 2008 Oct; 43(4):653-62. PubMed ID: 18582604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal remodeling following clinically relevant radiation-induced bone damage treated with zoledronic acid.
    Hui SK; Fairchild GR; Kidder LS; Sharma M; Bhattacharya M; Jackson S; Le C; Yee D
    Calcif Tissue Int; 2012 Jan; 90(1):40-9. PubMed ID: 22083107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accretion of bone mass and strength with parathyroid hormone prior to the onset of estrogen deficiency can provide temporary beneficial effects in skeletally mature rats.
    Shen V; Birchman R; Liang XG; Wu DD; Dempster DW; Lindsay R
    J Bone Miner Res; 1998 May; 13(5):883-90. PubMed ID: 9610753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of combined treatment with zoledronic acid and parathyroid hormone on mouse bone callus structure and composition.
    Casanova M; Herelle J; Thomas M; Softley R; Schindeler A; Little D; Schneider P; Müller R
    Bone; 2016 Nov; 92():70-78. PubMed ID: 27542660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination Therapy with Zoledronic Acid and Parathyroid Hormone Improves Bone Architecture and Strength following a Clinically-Relevant Dose of Stereotactic Radiation Therapy for the Local Treatment of Canine Osteosarcoma in Athymic Rats.
    Curtis RC; Custis JT; Ehrhart NP; Ehrhart EJ; Condon KW; Gookin SE; Donahue SW
    PLoS One; 2016; 11(6):e0158005. PubMed ID: 27332712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
    Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
    Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized rats.
    Washimi Y; Ito M; Morishima Y; Taguma K; Ojima Y; Uzawa T; Hori M
    Bone; 2007 Nov; 41(5):786-93. PubMed ID: 17707708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
    Shen V; Birchman R; Wu DD; Lindsay R
    J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential treatment with intermittent low-dose human parathyroid hormone (1-34) and bisphosphonate enhances large-size skeletal reconstruction by vascularized bone transplantation.
    Hashimoto T; Shigetomi M; Ohno T; Matsunaga T; Muramatsu K; Tanaka H; Sugiyama T; Taguchi T
    Calcif Tissue Int; 2007 Sep; 81(3):232-9. PubMed ID: 17674071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.
    Iida-Klein A; Lu SS; Cosman F; Lindsay R; Dempster DW
    Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single intravenous administration of zoledronic acid prevents the bone loss and mechanical compromise induced by aromatase inhibition in rats.
    Gasser JA; Green JR; Shen V; Ingold P; Rebmann A; Bhatnagar AS; Evans DB
    Bone; 2006 Oct; 39(4):787-95. PubMed ID: 16844441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis.
    Verdrengh M; Carlsten H; Ohlsson C; Tarkowski A
    J Orthop Res; 2007 Mar; 25(3):304-10. PubMed ID: 17089391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients.
    Santini D; Vincenzi B; Galluzzo S; Battistoni F; Rocci L; Venditti O; Schiavon G; Angeletti S; Uzzalli F; Caraglia M; Dicuonzo G; Tonini G
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4482-6. PubMed ID: 17671133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-treatment of PTH with osteoprotegerin or alendronate increases its anabolic effect on the skeleton of oophorectomized mice.
    Samadfam R; Xia Q; Goltzman D
    J Bone Miner Res; 2007 Jan; 22(1):55-63. PubMed ID: 17014384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronic acid prevents loss of trabecular bone after focal irradiation in mice.
    Keenawinna L; Oest ME; Mann KA; Spadaro J; Damron TA
    Radiat Res; 2013 Jul; 180(1):89-99. PubMed ID: 23772924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.